Scientific and ethical issues involved in the genetic screening of individuals with increased susceptibilities to developing occupationally related cancers were examined. Minimum scientific evidence required for the use of genetic screening tests were described. Difficulties associated with obtaining such minimum evidence were illustrated by examination of the genetic polymorphism associated with the activity of N-acetyltransferase, an enzyme associated with the activation and deactivation of carcinogenic arylamines, and the risk of bladder cancer among workers exposed to such chemicals. Drawbacks to the use of N-acetyltransferase polymorphism as a biological marker of susceptibility to cancer were discussed. These included unavoidable misclassifications resulting from poor correspondence between phenotype and genotype or intraindividual phenotype variability, variability in the data linking specific N-acetyltransferase polymorphisms with cancer risk dependent upon exposure and population, violation of the autonomy of workers, ethical considerations, and the potential for employment restrictions based upon prejudices such as gender, race, or ethnic group that may be associated with this polymorphism.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.